DOP2006000185A - Sal benzoato de 4-(5-metiloxazolo[4,5-b]piridin-2-il)-1,4-diazabiciclo[3,2,2]nonano - Google Patents

Sal benzoato de 4-(5-metiloxazolo[4,5-b]piridin-2-il)-1,4-diazabiciclo[3,2,2]nonano

Info

Publication number
DOP2006000185A
DOP2006000185A DO2006000185A DO2006000185A DOP2006000185A DO P2006000185 A DOP2006000185 A DO P2006000185A DO 2006000185 A DO2006000185 A DO 2006000185A DO 2006000185 A DO2006000185 A DO 2006000185A DO P2006000185 A DOP2006000185 A DO P2006000185A
Authority
DO
Dominican Republic
Prior art keywords
nonano
benzoate salt
methyllozazolo
diazabiciclo
piridin
Prior art date
Application number
DO2006000185A
Other languages
English (en)
Inventor
Allen Jocab Duplantier
Kenneth George Kraus
Bruuce Nelsen Rogers
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of DOP2006000185A publication Critical patent/DOP2006000185A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona una sal benzoato de formula 1: Formula I La formula I es tambien conocida como 4-(5-metiloxazolo[4,5-b]piridin-2-il)-1,4-diazabiciclo[3.2.2]nonano. La sal benzoato de la invención es util en el tratamiento de esquizofrenia y enfermedad de Alzheimer. Es particularmente util en el tratamiento de deficit cognitivos asociados a esquizofrenia, sintomas de deficit cognitivo y de atención de la enfermedad de Alzheimer y neurodegeneracibn asociada a la enfermedad de Alzheimer.
DO2006000185A 2005-08-08 2006-08-08 Sal benzoato de 4-(5-metiloxazolo[4,5-b]piridin-2-il)-1,4-diazabiciclo[3,2,2]nonano DOP2006000185A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70660105P 2005-08-08 2005-08-08

Publications (1)

Publication Number Publication Date
DOP2006000185A true DOP2006000185A (es) 2007-03-31

Family

ID=37398316

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2006000185A DOP2006000185A (es) 2005-08-08 2006-08-08 Sal benzoato de 4-(5-metiloxazolo[4,5-b]piridin-2-il)-1,4-diazabiciclo[3,2,2]nonano

Country Status (6)

Country Link
AR (1) AR055111A1 (es)
DO (1) DOP2006000185A (es)
NL (1) NL1032286C2 (es)
TW (1) TW200738734A (es)
UY (1) UY29731A1 (es)
WO (1) WO2007017750A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009113950A1 (en) * 2008-03-10 2009-09-17 Astrazeneca Ab Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
CN107188900B (zh) * 2017-05-27 2019-09-06 北京师范大学 α7烟碱型乙酰胆碱受体的配体化合物及其应用
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
WO2019243452A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086871A1 (en) * 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
WO2005063296A2 (en) * 2003-12-23 2005-07-14 Pfizer Products Inc. Therapeutic combination for cognition enhancement and psychotic disorders

Also Published As

Publication number Publication date
TW200738734A (en) 2007-10-16
UY29731A1 (es) 2007-03-30
AR055111A1 (es) 2007-08-08
NL1032286C2 (nl) 2007-08-07
WO2007017750A1 (en) 2007-02-15
NL1032286A1 (nl) 2007-02-09

Similar Documents

Publication Publication Date Title
DOP2006000185A (es) Sal benzoato de 4-(5-metiloxazolo[4,5-b]piridin-2-il)-1,4-diazabiciclo[3,2,2]nonano
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
ME01032B (me) FORME RIFAKSIMINA l NJIHOVA UPOTREBA
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
NZ600430A (en) Spiro-oxindole mdm2 antagonists
ATE495445T1 (de) Verfahren und zusammensetzungen in verbindung mit morbus alzheimer
IN2012DN00766A (es)
WO2012020848A8 (en) Heterocyclic compound and use thereof
CL2012001464A1 (es) Compuestos derivados de (2-amino-5,5-difluor-5,6-dihidro-4h-[1,3]oxazin-4-il)-fenilamida, inhibidores bace1 y/o bace2; composicion farmaceutica; procedimiento de preparacion; y uso en el tratamiento terapeutico y/o profilactico de enfermedades tales como alzheimer y diabetes.
PE20091977A1 (es) Compuestos de quinuclidina como ligandos del receptor nicotinico de acetilcolina alfa-7
RU2711869C3 (ru) Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk
WO2011045415A3 (en) Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
WO2009149486A3 (en) Compounds for treating beta-amyloidoses
GT200600011A (es) Procedimientos para preparar eteres de pirazolo [3,4-d] pirimidina
MY162640A (en) Thioninium compounds and their use
CL2008002689A1 (es) Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia.
EP2312946A4 (en) PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
UY29425A1 (es) Sal besilato de 7-(2- (4-(3- trifluorometil-fenil)-1,2,3,6-tetrahidro-pirid-1-il)etil) isoquinoleina, su preparacion y su utilización en terapéutica.-
CR11447A (es) Moduladores de piperidinil y piperazinil de y secretasa
DE602006002612D1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
ATE552251T1 (de) Thiophen- und furanverbindungen
CL2008000726A1 (es) Compuestos derivados de heterociclos nitrogenados condensados; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como esquizofrenia, alzheimer, entre otras.
WO2010011626A3 (en) Pyridinyl modulators of ϒ-secretase
NI201000067A (es) Intermediarios de gsm.
ATE496047T1 (de) Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien